16th Oct 2023 7:00 am |
RNS |
Jemperli plus chemotherapy positive CHMP opinion |
13th Oct 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
12th Oct 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
11th Oct 2023 7:00 am |
RNS |
Zantac (ranitidine) litigation |
10th Oct 2023 11:00 am |
RNS |
Holding(s) in Company |
9th Oct 2023 7:00 am |
RNS |
GSK and Zhifei announce vaccine partnership |
6th Oct 2023 7:00 am |
RNS |
GSK completes sale of shares in Haleon plc |
5th Oct 2023 4:46 pm |
RNS |
GSK announces intention to sell shares in Haleon |
2nd Oct 2023 3:00 pm |
RNS |
Total Voting Rights |
27th Sep 2023 3:00 pm |
RNS |
Directorate Change |
25th Sep 2023 7:00 am |
RNS |
GSK RSV vaccine for older adults approved in Japan |
21st Sep 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
19th Sep 2023 7:00 am |
RNS |
Apretude for PrEP receives EMA approval |
18th Sep 2023 7:00 am |
RNS |
FDA approves Ojjaara (momelotinib) |
13th Sep 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
11th Sep 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
11th Sep 2023 7:00 am |
RNS |
Momelotinib filing accepted in Japan |
1st Sep 2023 3:00 pm |
RNS |
Total Voting Rights |
1st Sep 2023 7:00 am |
RNS |
GSK’s Nucala CRSwNP submission accepted in Japan |
31st Aug 2023 3:16 pm |
RNS |
Holding(s) in Company |
31st Aug 2023 3:14 pm |
RNS |
Holding(s) in Company |
25th Aug 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
23rd Aug 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
23rd Aug 2023 7:00 am |
RNS |
Shingrix data demonstrate 100% efficacy in China |
22nd Aug 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
10th Aug 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
9th Aug 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
8th Aug 2023 1:05 pm |
RNS |
Publication of Base Prospectus |
1st Aug 2023 3:00 pm |
RNS |
Total Voting Rights |
31st Jul 2023 6:00 pm |
RNS |
FDA approves new use for Jemperli plus chemo |
31st Jul 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
28th Jul 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
26th Jul 2023 7:00 am |
RNS |
2nd Quarter Results |
24th Jul 2023 7:00 am |
RNS |
Cabotegravir LA for PrEP receives positive CHMP |
20th Jul 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
17th Jul 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
13th Jul 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
3rd Jul 2023 3:00 pm |
RNS |
Total Voting Rights |
28th Jun 2023 3:43 pm |
RNS |
GSK completes acquisition of BELLUS Health |
27th Jun 2023 7:00 am |
RNS |
FDA Fast Track for Gonorrhoea Vaccine Candidate |